Two novel glucagon receptor antagonists prove effective therapeutic agents in high-fat-fed and obese diabetic mice

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Aims: To examine the effect of two novel, enzymatically stable, glucagon receptor peptide antagonists, on metabolic control in two mouse models ofobesity/diabetes.Method: The effects of twice daily i.p. administration of desHis1Pro4Glu9-glucagon or desHis1Pro4Glu9Lys12FA-glucagon for 10 days on metaboliccontrol in high-fat-fed (HFF; 45% fat) and obese diabetic (ob/ob) mice were compared with saline-treated controls.Results: Neither analogue altered body weight or food intake in either model over 10 days; however, treatment with each peptide restored non-fastingblood glucose towards normal control values in HFF mice. Basal glucose was also reduced (p
Original languageEnglish
Pages (from-to)1214-1222
JournalDiabetes Obesity and Metabolism
Volume16
Issue number12
DOIs
Publication statusPublished - 1 Dec 2014

Fingerprint Dive into the research topics of 'Two novel glucagon receptor antagonists prove effective therapeutic agents in high-fat-fed and obese diabetic mice'. Together they form a unique fingerprint.

  • Cite this